Clearbridge Investments LLC increased its holdings in athenahealth, Inc (NASDAQ:ATHN) by 0.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 911,546 shares of the health services provider’s stock after buying an additional 1,351 shares during the period. Clearbridge Investments LLC’s holdings in athenahealth were worth $121,272,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Jefferies Group LLC acquired a new position in athenahealth during the 4th quarter valued at about $266,000. ArrowMark Colorado Holdings LLC boosted its stake in athenahealth by 30.1% during the 4th quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock valued at $68,098,000 after purchasing an additional 118,411 shares during the period. BlueCrest Capital Management Ltd acquired a new position in athenahealth during the 4th quarter valued at about $947,000. ETRADE Capital Management LLC acquired a new position in athenahealth during the 4th quarter valued at about $246,000. Finally, Alliancebernstein L.P. boosted its stake in athenahealth by 1.8% during the 4th quarter. Alliancebernstein L.P. now owns 22,790 shares of the health services provider’s stock valued at $3,032,000 after purchasing an additional 400 shares during the period.
A number of research analysts have issued reports on ATHN shares. KeyCorp reissued a “buy” rating and set a $152.00 target price on shares of athenahealth in a research note on Friday, January 12th. SunTrust Banks boosted their target price on shares of athenahealth to $180.00 and gave the company a “buy” rating in a research note on Monday, February 5th. Piper Jaffray Companies reissued a “buy” rating and set a $160.00 target price on shares of athenahealth in a research note on Friday, February 16th. Royal Bank of Canada set a $141.00 target price on shares of athenahealth and gave the company a “hold” rating in a research note on Thursday, February 15th. Finally, BidaskClub raised shares of athenahealth from a “sell” rating to a “hold” rating in a research note on Saturday, December 16th. Three analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and seven have issued a buy rating to the company. athenahealth presently has an average rating of “Hold” and a consensus price target of $144.35.
athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.48. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The business had revenue of $329.20 million for the quarter, compared to the consensus estimate of $319.64 million. During the same period in the previous year, the firm earned $0.62 EPS. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. analysts predict that athenahealth, Inc will post 2.69 earnings per share for the current fiscal year.
In related news, CEO Jonathan Bush sold 250 shares of the business’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $139.27, for a total value of $34,817.50. Following the sale, the chief executive officer now directly owns 321,533 shares in the company, valued at approximately $44,779,900.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CMO Timothy John O’brien sold 3,064 shares of the business’s stock in a transaction that occurred on Friday, March 2nd. The stock was sold at an average price of $137.27, for a total transaction of $420,595.28. Following the completion of the sale, the chief marketing officer now owns 11,320 shares in the company, valued at $1,553,896.40. The disclosure for this sale can be found here. Insiders sold a total of 108,705 shares of company stock worth $14,891,199 over the last quarter. Insiders own 3.20% of the company’s stock.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.